NCT05863884

Brief Summary

The proposed project will implement and evaluate a brief Community Health Worker (CHW) intervention through the Albany Area Primary Health Care, a rural Federally Qualified Health Center (FQHC). The primary goal of this study is to maximize effective outreach, education, and communication through CHWs in order to facilitate improved COVID-19 vaccine confidence and uptake in underserved and vulnerable communities. CHWs will be deployed to the homes of adults with increased risk of morbidity and mortality (i.e., African Americans or Latinos with uncontrolled diabetes or prediabetes, age \<50 years, and non-COVID-19 vaccinated) in order to educate them about diabetes, COVID-19 and related vaccines. Health assessments, including blood glucose measurement, will be conducted on the indexed patient and offered to all other adult family members in the household (i.e., "bubble"). Adults with Type 2 diabetes likely live in households with other adults who have or are at increased risk for diabetes (i.e., prediabetes and obesity).1 It is expected that they will also share similar COVID-19 exposure risk. The specific aims are to: 1) Evaluate a community-driven education program to increase and enhance COVID-19 vaccine confidence and uptake in individuals with uncontrolled diabetes and their families (i.e., their "bubble") and 2) Evaluate a community-driven education program to improve diabetes self-management behaviors and related outcomes (e.g., blood glucose) in individuals with uncontrolled diabetes in rural, Southwest Georgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P25-P50 for not_applicable diabetes

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 11, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2022

Completed
6 months until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

2.8 years

First QC Date

December 2, 2022

Last Update Submit

July 29, 2025

Conditions

Keywords

diabetesCOVID-19rural communitiesrural health centerrural populationcommunity health workers

Outcome Measures

Primary Outcomes (1)

  • Blood Glucose Level

    Change in HbA1c level from using clinical assessment parameters from week 1 to week 6.

    6 weeks

Secondary Outcomes (1)

  • Diabetes Self-Management Score

    6 weeks

Other Outcomes (1)

  • COVID-19 Vaccination Confidence and Uptake

    6 weeks

Study Arms (1)

CHW Intervention

OTHER

A six week CHW home-visit behavioral intervention examining changes in diabetes outcomes.

Behavioral: Impact of Community Health Worker Home Deployment on COVID-19 Vaccine Confidence and Uptake

Interventions

CHWs will conduct home visits to provide diabetes and COVID-19 health education based on the participant's needs, interests, and clinical health assessment results. All adults in the household will be invited to participate in the health education discussions. At each visit, the CHW will use diabetes management and COVID-19 educational materials to facilitate and inform discussions. CHWs will also make available at-home COVID-19 testing kits with instructions for the patient and their household family members. The discussion of COVID-19 beliefs, perceptions, and related behaviors will be raised during a later visit, i.e., after rapport and trust has been established and if it has not been raised by the participants during the earlier visits. In addition, CHWs will help schedule vaccination and healthcare appointments upon participant's interest.

CHW Intervention

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants must be between18 and 50 years
  • Self-identify as African American/Black or Latino
  • English speaking
  • Have received care for uncontrolled diabetes (HbA1c \> 9%) or prediabetes diagnosis within one of the AAPHC 27 community sites
  • Unvaccinated for Phase 1 (vaccinated for Phase 2)

You may not qualify if:

  • Enrolled in the parent RADx-UP Project PEACH study
  • Unable or unwilling to provide informed consent to participate in the study (ie: incarcerated individuals and children)
  • Individuals with a terminal cancer diagnosis, have chronic kidney disease (stage 4-5), pregnant women, and people with severe psychological disorders (i.e., dementia,suicide ideation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Albany Area Primary Health Care

Albany, Georgia, 31707, United States

Location

MeSH Terms

Conditions

Diabetes MellitusCOVID-19Health BehaviorBehavior

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Rakale C Quarells, PhD

    Morehouse School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2022

First Posted

May 18, 2023

Study Start

February 11, 2022

Primary Completion

November 30, 2024

Study Completion

April 30, 2025

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations